CRLBF
Price
$1.18
Change
-$0.20 (-14.49%)
Updated
Sep 3 closing price
Capitalization
408.63M
64 days until earnings call
CURLF
Price
$2.74
Change
-$0.18 (-6.16%)
Updated
Sep 3 closing price
Capitalization
2.12B
67 days until earnings call
Interact to see
Advertisement

CRLBF vs CURLF

Header iconCRLBF vs CURLF Comparison
Open Charts CRLBF vs CURLFBanner chart's image
Cresco Labs
Price$1.18
Change-$0.20 (-14.49%)
Volume$2.41M
Capitalization408.63M
Curaleaf
Price$2.74
Change-$0.18 (-6.16%)
Volume$784.45K
Capitalization2.12B
CRLBF vs CURLF Comparison Chart in %
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. CURLF commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and CURLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CRLBF: $1.18 vs. CURLF: $2.74)
Brand notoriety: CRLBF and CURLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRLBF: 194% vs. CURLF: 62%
Market capitalization -- CRLBF: $408.63M vs. CURLF: $2.12B
CRLBF [@Pharmaceuticals: Generic] is valued at $408.63M. CURLF’s [@Pharmaceuticals: Generic] market capitalization is $2.12B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.55B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileCURLF’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • CURLF’s FA Score: 0 green, 5 red.
According to our system of comparison, CURLF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 2 TA indicator(s) are bullish while CURLF’s TA Score has 3 bullish TA indicator(s).

  • CRLBF’s TA Score: 2 bullish, 4 bearish.
  • CURLF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CRLBF and CURLF are a bad buy in the short-term.

Price Growth

CRLBF (@Pharmaceuticals: Generic) experienced а -17.08% price change this week, while CURLF (@Pharmaceuticals: Generic) price change was -14.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.02%. For the same industry, the average monthly price growth was +9.86%, and the average quarterly price growth was +87.27%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

CURLF is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.02% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.12B) has a higher market cap than CRLBF($409M). CURLF YTD gains are higher at: 75.641 vs. CRLBF (29.141). CURLF has higher annual earnings (EBITDA): 220M vs. CRLBF (136M). CRLBF has more cash in the bank: 147M vs. CURLF (102M). CRLBF has less debt than CURLF: CRLBF (631M) vs CURLF (843M). CURLF has higher revenues than CRLBF: CURLF (1.29B) vs CRLBF (685M).
CRLBFCURLFCRLBF / CURLF
Capitalization409M2.12B19%
EBITDA136M220M62%
Gain YTD29.14175.64139%
P/E RatioN/AN/A-
Revenue685M1.29B53%
Total Cash147M102M144%
Total Debt631M843M75%
FUNDAMENTALS RATINGS
CRLBF vs CURLF: Fundamental Ratings
CRLBF
CURLF
OUTLOOK RATING
1..100
2118
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (49) in the null industry is in the same range as CRLBF (79). This means that CURLF’s stock grew similarly to CRLBF’s over the last 12 months.

CURLF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that CURLF’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as CURLF (96). This means that CRLBF’s stock grew similarly to CURLF’s over the last 12 months.

CRLBF's Price Growth Rating (34) in the null industry is in the same range as CURLF (34). This means that CRLBF’s stock grew similarly to CURLF’s over the last 12 months.

CRLBF's P/E Growth Rating (100) in the null industry is in the same range as CURLF (100). This means that CRLBF’s stock grew similarly to CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFCURLF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSHX25.29N/A
N/A
MFS Research International R3
CVLCX11.06N/A
N/A
Calamos Global Opportunities C
MSMJX31.48N/A
N/A
Invesco Main Street Mid Cap R5
EILGX19.45N/A
N/A
Eaton Vance Atlanta Capital Focused Gr I
ABLOX23.98N/A
N/A
Alger Balanced I-2

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-14.49%
TSNDF - CRLBF
76%
Closely correlated
-12.08%
CURLF - CRLBF
76%
Closely correlated
-6.17%
TCNNF - CRLBF
75%
Closely correlated
-8.65%
JUSHF - CRLBF
74%
Closely correlated
-8.37%
VRNOF - CRLBF
73%
Closely correlated
-13.70%
More

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
-6.17%
GTBIF - CURLF
82%
Closely correlated
-7.39%
TCNNF - CURLF
80%
Closely correlated
-8.65%
VRNOF - CURLF
78%
Closely correlated
-13.70%
CRLBF - CURLF
76%
Closely correlated
-14.49%
TSNDF - CURLF
75%
Closely correlated
-12.08%
More